Single- and repeated-dose toxicity studies on the novel HIV maturation inhibitor QF-036 in Sprague-Dawley rats
- 4 May 2020
- journal article
- research article
- Published by Elsevier BV in Toxicology Letters
- Vol. 329, 26-30
- https://doi.org/10.1016/j.toxlet.2020.04.015
Abstract
No abstract availableKeywords
Funding Information
- Project of Shandong Province Higher Educational Science and Technology Program (J14LM04)
- National New Drug Innovation Major Project of China (2018ZX09711001-003-018)
This publication has 8 references indexed in Scilit:
- Discovery of a novel and potent class of anti-HIV-1 maturation inhibitors with improved virology profile against gag polymorphismsBioorganic & Medicinal Chemistry Letters, 2017
- Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation InhibitorsPLoS Pathogens, 2016
- Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral ActivityACS Medicinal Chemistry Letters, 2016
- Synthesis and Biological Evaluation of Macrocyclized Betulin Derivatives as a Novel Class of Anti-HIV-1 Maturation InhibitorsThe Open Medicinal Chemistry Journal, 2014
- Novel Targets for Antiretroviral TherapyDrugs, 2009
- Bevirimat: A Novel Maturation Inhibitor for the Treatment of HIV-1 InfectionAntiviral Chemistry and Chemotherapy, 2008
- A Population-Based Approach to Determine the Prevalence of Transmitted Drug-Resistant HIV Among Recent Versus Established HIV InfectionsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processingProceedings of the National Academy of Sciences of the United States of America, 2003